# C_2015401EN.01000601.xml

| 3.12.2015 | EN | Official Journal of the European Union | C 401/6 |
| --- | --- | --- | --- |

3.12.2015

EN

Official Journal of the European Union

C 401/6

---

Prior notification of a concentration

(Case M.7837 — The Goldman Sachs Group/The Wellcome Trust)

Candidate case for simplified procedure

(Text with EEA relevance)

(2015/C 401/06)

| 1. | On 27 November 2015, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which The Goldman Sachs Group, Inc. (‘Goldman Sachs’, United Kingdom) and The Wellcome Trust Limited (‘Wellcome’, United Kingdom) acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of JVco (Luxembourg) by way of purchase of shares in a newly created company constituting a joint venture. |
| --- | --- |

1.

On 27 November 2015, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which The Goldman Sachs Group, Inc. (‘Goldman Sachs’, United Kingdom) and The Wellcome Trust Limited (‘Wellcome’, United Kingdom) acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of JVco (Luxembourg) by way of purchase of shares in a newly created company constituting a joint venture.

1

| 2. | The business activities of the undertakings concerned are:
  —   for Goldman Sachs: a range of banking, securities and investment services worldwide to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-wort individuals,
  —   for Wellcome: Managing an investment portfolioto provide the income for funding its central aim of achieving improvements in human and animal health,
  —   for JVco: combining the relevant Goldman Sachs and Wellcome Trust owned student accommodation businesses in the UK, branded ‘Prodigy Living’ and ‘iQ Students’ respectively. |
| --- | --- |

2.

The business activities of the undertakings concerned are:

—   for Goldman Sachs: a range of banking, securities and investment services worldwide to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-wort individuals,

for Goldman Sachs

—   for Wellcome: Managing an investment portfolioto provide the income for funding its central aim of achieving improvements in human and animal health,

for Wellcome

—   for JVco: combining the relevant Goldman Sachs and Wellcome Trust owned student accommodation businesses in the UK, branded ‘Prodigy Living’ and ‘iQ Students’ respectively.

for JVco

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7837 — The Goldman Sachs Group/The Wellcome Trust, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7837 — The Goldman Sachs Group/The Wellcome Trust, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---